IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum]
Authors Zhou X, Feng Y, Liu S, Li C, Teng Y, Li X, Lu J
Received 24 March 2021
Accepted for publication 24 March 2021
Published 30 March 2021 Volume 2021:13 Pages 2907—2908
Zhou X, Feng Y, Liu S, et al. Cancer Manag Res. 2021;13:2379–2388.
The authors have advised that the funding statement on page 2387 is incorrect. The text “The project was supported by Cadre Health Research Project of Jiangsu Province (BJI18033) and Youth Project of Nanjing Medical University Affiliated Cancer Hospital (ZN201603)” should read “The project was supported by Cadre Health Research Project of Jiangsu Province (BJ18033) and Youth Project of Nanjing Medical University Affiliated Cancer Hospital (ZN201603)”.
The authors apologize for this error.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]